Sessile serrated adenomas with dysplasia: Morphological patterns and correlations with MLH1 immunohistochemistry

Modern Pathology

Volumn 30, Issue 12, 2017, Pages 1728-1738

  Liu, Cheng ^a,b   Walker, Neal I ^b,c   Leggett, Barbara A ^a,b,d   Whitehall, Vicki Lj ^a,b,e   Bettington, Mark L ^b,c   Rosty, Christophe ^b,c,f  

^a QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

^c Envoi Specialist Pathologists   (United States)

^d ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

^e Pathology Queensland ^*  (Australia)

^f UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

MUTL PROTEIN HOMOLOG 1; MLH1 PROTEIN, HUMAN; TUMOR MARKER;

ADULT; AGED; ARTICLE; COLON MUCOSA; COLORECTAL CARCINOMA; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; DYSPLASIA; FEMALE; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTESTINE CRYPT; MAJOR CLINICAL STUDY; MALE; MORPHOLOGY; PRIORITY JOURNAL; RECTUM ADENOMA; RETROSPECTIVE STUDY; VERY ELDERLY; ADENOMA; BIOSYNTHESIS; COLORECTAL TUMOR; MIDDLE AGED; PATHOLOGY;

ADENOMA; ADULT; AGED; AGED, 80 AND OVER; BIOMARKERS, TUMOR; COLORECTAL NEOPLASMS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; MUTL PROTEIN HOMOLOG 1;

EID: 85037035399     PISSN: 08933952     EISSN: 15300285     Source Type: Journal    
DOI: 10.1038/modpathol.2017.92     Document Type: Article

References (27)

1. Bettington M, Walker N, Rosty C, et al. Critical appraisal of the diagnosis of the sessile serrated adenoma. Am J Surg Pathol 2014;38:158-166.
2. Lash RH, Genta RM, Schuler CM. Sessile serrated adenomas: prevalence of dysplasia and carcinoma in 2139 patients. J Clin Pathol 2010;63:681-686.
3. Pai RK, Hart J, Noffsinger AE. Sessile serrated adenomas strongly predispose to synchronous serrated polyps in non-syndromic patients. Histopathology 2010;56:581-588.
4. Bettington M, Walker N, Clouston A, et al. The serrated pathway to colorectal carcinoma: current concepts and challenges. Histopathology 2013;62:367-386.
5. O'Brien MJ, Zhao Q, Yang S. Colorectal serrated pathway cancers and precursors. Histopathology 2015;66:49-65.
6. Rosty C, Hewett DG, Brown IS, et al. Serrated polyps of the large intestine: current understanding of diagnosis, pathogenesis, and clinical management. J Gastroenterol 2013;48:287-302.
7. IJspeert JE, Vermeulen L, Meijer GA, et al. Serrated neoplasia-role in colorectal carcinogenesis and clinical implications. Nat Rev Gastroenterol Hepatol 2015;12: 401-409.
8. Nanda KS, Tutticci N, Burgess N, et al. Caught in the act: endoscopic characterization of sessile serrated adenomas with dysplasia. Gastrointest Endosc 2014;79: 864-870.
9. Pohl H, Srivastava A, Bensen SP, et al. Incomplete polyp resection during colonoscopy-results of the complete adenoma resection (CARE) study. Gastroenterology 2013;144:74-80 e71.
10. Bettington M, Walker N, Rosty C, et al. Clinicopathological and molecular features of sessile serrated adenomas with dysplasia or carcinoma. Gut 2017;66: 97-106.
11. Yang JF, Tang SJ, Lash RH, et al. Anatomic distribution of sessile serrated adenoma/polyp with and without cytologic dysplasia. Arch Pathol Lab Med 2015;139: 388-393.
12. Snover DC. Update on the serrated pathway to colorectal carcinoma. Hum Pathol 2011;42:1-10.
13. Sheridan TB, Fenton H, Lewin MR, et al. Sessile serrated adenomas with low-and high-grade dysplasia and early carcinomas: An immunohistochemical study of serrated lesions 'caught in the act'. Am J Clin Pathol 2006;126:564-571.
14. Snover DC, Ahnen DJ, Burt RW, et al. Serrated polyps of the colon and rectum and serrated polyposis. In: Bosman FT, Carneiro F, Hruban RH, Theise ND (eds). WHO Classification of Tumours of the Digestive System. IARC Press: Lyon, France, 2010, pp 160-165.
15. Bettington ML, Walker NI, Rosty C, et al. A clinicopathological and molecular analysis of 200 traditional serrated adenomas. Mod Pathol 2015;28: 414-427.
16. Burgess NG, Tutticci NJ, Pellise M, et al. Sessile serrated adenomas/polyps with cytologic dysplasia: A triple threat for interval cancer. Gastrointest Endosc 2014;80:307-310.
17. Chino A, Nagayama S, Ishikawa H, et al. Cancer emerging from the recurrence of sessile serrated adenoma/polyp resected endoscopically 5 years ago. Jpn J Clin Oncol 2016;46:89-95.
18. Hawkins NJ, Ward RL. Sporadic colorectal cancers with microsatellite instability and their possible origin in hyperplastic polyps and serrated adenomas. J Natl Cancer Inst 2001;93:1307-1313.
19. Jass JR, Young J, Leggett BA. Hyperplastic polyps and DNA microsatellite unstable cancers of the colorectum. Histopathology 2000;37:295-301.
20. Oh K, Redston M, Odze RD. Support for hMLH1 and MGMT silencing as a mechanism of tumorigenesis in the hyperplastic-adenoma-carcinoma (serrated) carcinogenic pathway in the colon. Hum Pathol 2005;36: 101-111.
21. Kloor M, Huth C, Voigt AY, et al. Prevalence of mismatch repair-deficient crypt foci in Lynch syndrome: A pathological study. Lancet Oncol 2012;13: 598-606.
22. Phipps AI, Limburg PJ, Baron JA, et al. Association between molecular subtypes of colorectal cancer and patient survival. Gastroenterology 2015;148:77-87 e72.
23. Rosty C, Williamson EJ, Clendenning M, et al. Microsatellite instability and BRAF mutation testing in colorectal cancer prognostication. J Natl Cancer Inst 2014;106.
24. Ban S, Mitomi H, Horiguchi H, et al. Adenocarcinoma arising in small sessile serrated adenoma/polyp (SSA/P) of the colon: clinicopathological study of eight lesions. Pathol Int 2014;64:123-132.
25. Fujita K, Yamamoto H, Matsumoto T, et al. Sessile serrated adenoma with early neoplastic progression: A clinicopathologic and molecular study. Am J Surg Pathol 2011;35:295-304.
26. Goldstein NS. Small colonic microsatellite unstable adenocarcinomas and high-grade epithelial dysplasias in sessile serrated adenoma polypectomy specimens: A study of eight cases. Am J Clin Pathol 2006;125: 132-145.
27. Kim KM, Lee EJ, Ha S, et al. Molecular features of colorectal hyperplastic polyps and sessile serrated adenoma/polyps from Korea. Am J Surg Pathol 2011;35:1274-1286.